Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD4 | P21917 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 6/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28959772 | 1.00 | KMT2A (0.36) | KMT2ADRD2DRD4LMNACYP1A2 | |
| SCHEMBL24931443 | 1.00 | KMT2A (0.36) | KMT2ADRD2DRD4LMNACYP1A2 | |
| SCHEMBL12355494 | 0.84 | ATM (0.35) | L3MBTL1 | |
| SCHEMBL20318601 | 0.83 | CYP19A1 (0.40) | LMNACYP1A2CYP3A4CYP11B1CYP11B2 | |
| SCHEMBL18623188 | 0.81 | ALDH1A1 (0.46) | DRD2DRD4LMNACYP1A2CYP3A4 | |
| SCHEMBL22981935 | 0.81 | TBXAS1 (0.37) | KMT2ADRD2DRD4LMNACYP1A2 | |
| SCHEMBL18604872 | 0.81 | ALDH1A1 (0.46) | DRD2DRD4LMNACYP1A2CYP3A4 | |
| SCHEMBL22981937 | 0.81 | TBXAS1 (0.37) | KMT2ADRD2DRD4LMNACYP1A2 | |
| SCHEMBL2241783 | 0.80 | L3MBTL1 (0.36) | LMNATDP1L3MBTL1 | |
| SCHEMBL2241789 | 0.80 | L3MBTL1 (0.36) | LMNATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230025652-A1 | METHOD FOR PREPARING CHIRAL SYNTHETIC NICOTINE | SHENZHEN ZINWI BIO-TECH CO., LTD (CN) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230025652-A1 | METHOD FOR PREPARING CHIRAL SYNTHETIC NICOTINE | CHRNB1, CHRNB4, CHRNB3 | KMT2A 634/4885DRD2 1314/4885DRD4 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.